As a transcription factor, CTCF utilizes different sets of zinc fingers to bind target sequences [66], and exerts oncogenic roles in NB progression through activating oncogene (MYCN) or repressing tumor suppressors such as forkhead box D3 (FOXD3) [11, 13]. The gene discussed is CTCF; the disease is neoplasm.